dimethylphenylpiperazinium iodide has been researched along with Cardiac Failure in 1 studies
Dimethylphenylpiperazinium Iodide: A selective nicotinic cholinergic agonist used as a research tool. DMPP activates nicotinic receptors in autonomic ganglia but has little effect at the neuromuscular junction.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bibevski, S | 1 |
| Dunlap, ME | 1 |
1 other study available for dimethylphenylpiperazinium iodide and Cardiac Failure
| Article | Year |
|---|---|
Prevention of diminished parasympathetic control of the heart in experimental heart failure.
Topics: Animals; Dimethylphenylpiperazinium Iodide; Dogs; Heart; Heart Failure; Male; Nicotinic Agonists; Pa | 2004 |